The data is big. The applications are bigger.
Rosalind Franklin crystallized DNA
Innovative tools + analysis to better identify signatures of disease
Find New Targets
Deep phenotyping reveals genome - and disease - level associations
Personalized tools improve data collection to impact care now
Advancing Healthcare with
Genomes & Phenomes
Improve identification of rare disorders
A large portion of participants in the whole genome sequencing diagnostic program will be diagnosed with a rare, often monogenic, condition. Due to complex clinical presentation, traditional research methods have struggled to identify the full spectrum of patients harboring pathogenic variants for these diseases. Our program will diagnose rare disease and provide critical insights about the full spectrum of symptoms and patient experiences.
Identify new therapeutic targets
Whole genome sequencing reveals regulatory and intronic regions of DNA that modulate clinical symptoms and the effects other genetic variants. Our rich data set enables analysis of these complex patterns within complex biological networks and the identification of genetic modifiers as therapeutic targets, a strong advantage over exome- or gene-level data for developing targeted therapies.
Clarify the effects of common variants
Our ability to engage patients in long term research opens the door for exploring many facets of genetics, including common variants with small but cumulative effects on health. IDG encourages patients from our diagnostic programs to register for Health Stories to shed light on the full impact of these variants on health.
Contribute to the fine mapping of the genome
Through partnerships with strong computational groups, especially our Stanford University collaborators, IDG's programs collect data to uncover numerous details of genome regulation and function. Pairing rich data with deep learning and cloud computing accelerates discovery.
Improve disease classifications
Clinical symptoms that seem similar may have distinct genetic causes. Modern medicine targets the root cause of symptoms to improve treatment outcomes. Deep phenotyping and genome sequecning increase the precision of diagnosis and offer a new lens to healthcare.
Track and decode VUS
Variants of unknown significance (VUS) will be identified and reported in many of our participants. Through all of our research programs, we will track and monitor correlations between these variants and health outcomes. Decoding all of the genetic markers in the human genome requires rich data and a focused approach.
Collaborate with In-Depth Genomics
Share your vision.
We continuously explore new directions for research and data application. Proposals are welcomed on a rolling basis from active researchers in medicine, academia, advocacy, and industry. To get the conversation going, please submit a brief description of yourself and your collaboration interests.